• STJ70979 (0. 1µg/ml) staining of NIH/3T3 lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.

Anti-APBB1/FE65 antibody (C-Term) (STJ70979)

SKU:
STJ70979-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-APBB1/FE65 (C-Term) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: ELISA-antibody detection limit dilution 1:128000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: APBB1
Gene ID: 322
Uniprot ID: APBB1_HUMAN
Immunogen Region: C-Term
Accession Number: NP_001155.1; NP_663722.1
Specificity: This antibody is expected to recognise both reported isoforms (NP_001155.1 and NP_663722.1).
Immunogen Sequence: GSLKPKRLGAHTP
Post Translational Modifications Phosphorylation at Ser-610 by SGK1 promotes its localization to the nucleus. Phosphorylated following nuclear translocation. Phosphorylation at Tyr-547 by ABL1 enhances transcriptional activation activity and reduces the affinity for RASD1/DEXRAS1. Acetylation at Lys-204 and Lys-701 by KAT5 promotes its transcription activator activity. Polyubiquitination by RNF157 leads to degradation by the proteasome.
Function Transcription coregulator that can have both coactivator and corepressor functions. Adapter protein that forms a transcriptionally active complex with the gamma-secretase-derived amyloid precursor protein (APP) intracellular domain. Plays a central role in the response to DNA damage by translocating to the nucleus and inducing apoptosis. May act by specifically recognizing and binding histone H2AX phosphorylated on 'Tyr-142' (H2AXY142ph) at double-strand breaks (DSBs), recruiting other pro-apoptosis factors such as MAPK8/JNK1. Required for histone H4 acetylation at double-strand breaks (DSBs). Its ability to specifically bind modified histones and chromatin modifying enzymes such as KAT5/TIP60, probably explains its transcription activation activity. Functions in association with TSHZ3, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s). Involved in hippocampal neurite branching and neuromuscular junction formation, as a result plays a role in spatial memory functioning. Plays a role in the maintenance of lens transparency. May play a role in muscle cell strength.
Protein Name Amyloid Beta Precursor Protein Binding Family B Member 1
Amyloid-Beta A4 Precursor Protein-Binding Family B Member 1
Protein Fe65
Database Links Reactome: R-HSA-5693565
Cellular Localisation Cell Membrane
Cytoplasm
Nucleus
Cell Projection
Growth Cone
Nucleus Speckle
Colocalizes With Tshz3 In Axonal Growth Cone
Colocalizes With Tshz3 In The Nucleus
In Normal Conditions
It Mainly Localizes To The Cytoplasm
While A Small Fraction Is Tethered To The Cell Membrane Via Its Interaction With App
Following Exposure To Dna Damaging Agents
It Is Released From Cell Membrane And Translocates To The Nucleus
Nuclear Translocation Is Under The Regulation Of App
Colocalizes With Nek6 At The Nuclear Speckles
Phosphorylation At Ser-610 By Sgk1 Promotes Its Localization To The Nucleus
Alternative Antibody Names Anti-Amyloid Beta Precursor Protein Binding Family B Member 1 antibody
Anti-Amyloid-Beta A4 Precursor Protein-Binding Family B Member 1 antibody
Anti-Protein Fe65 antibody
Anti-APBB1 antibody
Anti-FE65 antibody
Anti-RIR antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance